India  

First drug for severe form of fatty liver disease approved

IndiaTimes Friday, 15 March 2024
Fatty liver disease, hepatic steatosis, NAFLD, NASH, liver cirrhosis, FDA approves Rezdiffra, Madrigal Pharmaceuticals, liver scarring, Nikolay Nikolov. Disease linked to obesity, high cholesterol, diabetes, alcohol abuse, with medication focusing on liver damage treatment.
0
shares
ShareTweetSavePostSend
 

You Might Like


Related videos from verified sources

Liv Pure- Supplement [Video]

Liv Pure- Supplement

Introducing Liv Pure, a revolutionary product designed to optimize liver function and help combat stubborn belly fat. Scientists have discovered that compromised liver function is a common factor in..

Credit: Rumble     Duration: 01:03Published

Related news from verified sources

US approves first medication for severe non-alcoholic fatty liver disease

The FDA has approved Rezdiffra, the first medication for severe non-alcoholic fatty liver disease, showing improvement in liver scarring in NASH patients. NASH...
IndiaTimes